ReportWire

Tag: drug testing

  • New York Tech, UC Irvine create 3D-printed human colon model | Long Island Business News

    Researchers at the New York Institute of Technology and the University of California, Irvine (UC Irvine) have developed what’s described as a highly realistic artificial human colon, a scientific advancement that may improve preclinical testing for cancer treatments and expand research capabilities in gastrointestinal diseases.

    A new study in “Advanced Science” details the development of what may be the first functional, drug-testable, 3D-printed human colon model. Designed to provide an alternative to animal testing, the model closely replicates the structural and biological complexity of human colon tissue. Conceived by Steven Zanganeh, a bioengineer at New York Institute of Technology, with a campus in Old Westbury, the project aims to advance colorectal cancer research and support the development of precision therapies, while also laying the groundwork for realistic models of other human organs.

    “This is, to our knowledge, the first model of its kind and represents a true leap forward in biomedical innovation,” Zanganeh, who aims to commercialize the prototype, said in a news release about the model.

    “While this project successfully replicated a human colon, it also opens doors to create functional tissue for virtually any human organ,” Zanganeh said.

    “This breakthrough points to a future in which therapeutic testing can be performed without dependence on traditional cell cultures or animal models, streamlining the path to clinical trials,” he added. “What once sounded like science fiction is now reality.”

    Using human CT scan data, the team created a detailed anatomical map of the colon and employed bioprinting with hydrogels to fabricate a model that mimics key structural layers and functions. Printed at a UC Irvine facility, the model also supported the introduction and treatment of a tumor, offering a new platform for cancer drug discovery and disease research.

    “Our 3-D, human-relevant colon model overcomes key limitations of 2-D cell cultures and animal studies,” Rahim Esfandyar-Pour, assistant professor of electrical engineering and computer science at UC Irvine, said in the news release. “It lets us study disease and drug responses in a way that is far closer to the patient, opening a faster, more reliable path to new therapies.”

    Zanganeh and his team – including doctoral, graduate and medical students from New York Tech – plan to develop additional 3D tissue models. These prototypes aim to withstand electrical stimulation – recreating conditions that transport substances and molecules across cell membranes –  and those replicating immune function.

    “By combining cutting-edge bioprinting with interdisciplinary collaboration, Dr. Zanganeh and his colleagues have opened a new frontier in cancer research,” Babak Beheshti, dean of New York Tech’s College of Engineering and Computing Sciences, said in the news release.

    “We are proud to see our faculty leading discoveries with the potential to transform medicine and improve lives worldwide,” Beheshti said.


    Adina Genn

    Source link

  • DEA Re-Hires Agent Who Was Fired for Taking CBD | High Times

    DEA Re-Hires Agent Who Was Fired for Taking CBD | High Times


    The Department of Justice has rescinded a DEA decision to fire a special agent who was let go due to a positive reading for CBD on a drug test.

    DEA special agent Anthony L. Armour will be re-hired as a special agent and be reimbursed for back pay and legal expenses after a years-long court battle that stretches back to 2019 when a routine drug test showed he had been using CBD, which Armour maintained in court was for the purpose of treating chronic pain in lieu of highly-addictive opioid based painkillers.

    “I’m excited to be getting back to work at DEA,” Armour said to The New York Times. “I hope to finish my career at DEA by helping its mission in taking dangerous drugs like fentanyl off the streets.”

    Armour’s battle with chronic pain goes back to an injury he sustained during his college football career. He was also injured on the job as a DEA agent in a car crash during a surveillance operation, after which he suffered from back pain and a sprained neck. He ordered CBD products and a vaporizer from the internet, under the impression that he was not taking any illegal risks as the 2018 Farm Bill federally legalized hemp products. 

    “For Armour and many others in this country, this change meant new opportunities—particularly as to CBD, a non-THC cannabinoid in the cannabis plant,” a portion of the lawsuit said. “Armour hoped CBD oils could play a role in his pain management. That he did is unsurprising. From Martha Stewart to Wrigley Field, CBD has become embedded in American culture.”

    After he failed the drug test, Agent Armour turned the CBD products he had ordered into his superiors. Under federal law, hemp-derived products are defined as such if they contain less than 0.3% THC (please follow these handy-dandy little hyperlinks if you want more information on the clusterfuck of loopholes the Farm Bill created with regard to hemp-derived cannabis products). Of the three different hemp-based products Agent Armour turned in, court documents showed that two of them tested within the 0.3% THC range but one of them tested above the allowed threshold at 0.35%, which could be due to the notoriously unreliable potencies of hemp products and the methods by which they are tested.

    The DEA even went so far as to double down on their decision years into the lawsuit in late August of 2023. They filed a court brief defending Agent Armour’s termination just days before the Department of Health and Human Services officially recommended the federal rescheduling of cannabis from Schedule 1 to Schedule 3. The DEA also issued an official notice to all DEA employees after Armour’s termination to avoid all CBD products despite their federally legal status.

    “Mr. Armour was an outstanding DEA agent when he took a chance in 2019. He believed it was unlikely that CBD products would cause him to test positive for marijuana, but he knew it was possible, and he bought those unregulated products on the internet and consumed them anyway,” the DEA brief said. “Mr. Armour argues that he ‘displayed negligence or poor decision-making,’ and DEA properly held him accountable for his poor decisions when they resulted in a verified positive drug test. DEA lost trust in Mr. Armour and properly removed him.”

    Despite a years-long fight to keep Agent Armour off the payroll the DEA has agreed to reinstate him and pay him $470,000 in back pay and legal fees, according to the New York Times who obtained a copy of the court filings from earlier this month. Agent Armour told the New York Times he still sees value in using CBD for pain management but that he will consult a medical professional for viable alternatives upon his return to work. 

    “Federal drug testing policies—and importantly, attitudes about drug testing—have not caught up with the times. I’m not the only career law enforcement officer in this country with chronic pain, nor am I the only law enforcement officer that has turned to legal cannabis products to address pain,” Agent Armour said in court testimony in September. “Nobody should have to choose between suffering pain and serving our country.”



    Patrick Maravelias

    Source link

  • The Most Popular Vape Strains

    The Most Popular Vape Strains

    The Data has been checked twice, here are the top Vape strains making you go ho ho ho for the holidays

    This could be the most green Christmas ever.  With Canada and over 50% of Americans have access to legal weed, it is definitely going to be a high holiday for millions.  Marijuana will be helping spread the cheer, decrease the anxiety, prevent ugly fights and guide people to the land of nod.

    RELATED: The Most Popular Marijuana Flavors

    BDSA, a leading data antalytics company with a focus on cannabis, has shared the most popular vape strains going into the holiday season.  While flower continues to have a hold on afficiandos and revenue, vaping is right behind with both.  Vaping is also the perfect on-the-go vehicle to enjoy at a party, concert, or just a long walk. No major smell, easy to control dosage and easy to use, it is highly popular with all ages.

    Photo by FatCamera/Getty Images

    Here are the most popular vape strains:

    Blue Dream

    This strain is a sativa-dominant hybrid. It produces a balanced high, along with effects such as cerebral stimulation and full-body relaxation. It is popular with both canna-newbies and veteran consumers. Medical marijuana patients often use it to treat symptoms of depression, chronic pain, and nausea.

    Pineapple Express

    This is a sativa-dominant hybrid strain. While this strain rose to fame with the 2008  the release of Pineapple Express, it is a real strain found in dispensaries across the country. A consumer of cannabis lovers, it produces long-lasting energetic effects making you feel buzzy, alert, and creative. The best time to smoke Pineapple Express is in the morning, afternoon, or early evening hours. Medical marijuana patients use it to relieve symptoms associated with depression, pain, and fatigue.

    RELATED: People Who Use Weed Also Do More Of Another Fun Thing

    Strawberry Cough

    This strain has a sweet smell of fresh strawberries and an expanding sensation which can make even the most seasoned consumer cough. it is a potent sativa strain with mysterious genetic origins. The skunky, berry flavors capture the senses while the cerebral, uplifting effects provide an aura of euphoria. Strawberry Cough is a great solution in times of elevated stress.

    Granddaddy Purple

    This strain’s potent effects are clearly detectable in both mind and body, delivering a fusion of euphoria and physical relaxation. While thoughts may float in a dreamy buzz, the body is more likely to find itself fixed in one spot for the duration. Granddaddy Purple is typically pulled off the shelf for consumers looking to combat pain, stress, insomnia, appetite loss, and muscle spasms.

    Gelato

    This strain is an evenly-balanced hybrid marijuana strain made from a crossing of Sunset Sherbet and Thin Mint Girl Scout Cookies. It is a balance of indica & sativa producing a euphoric high accompanied by feelings of relaxation. Consumers who have smoked Gelato say the effects of the strain come quickly. You’ll be left feeling numb to pain, relaxed, but mentally stimulated and productive.

    Anthony Washington

    Source link

  • What You Need To Know About Drug Tests

    What You Need To Know About Drug Tests

    Roughly 1.47% of US job postings mention required pre-employment drug tests and only 0.66% mention regular drug testing.

    The good news is only about 1.47% of US job postings mention required pre-employment drug tests and only 0.66% mention regular drug testing. Yet, a majority of large companies, airlines, and some state and the federal governments still require testing.  Here is what you need to know about drug tests.

    A urine test is the prevalent form of pre-employment drug testing. Hair testing has a longer detection window for drug use spanning up to 90 days. Oral fluid testing is 100% observed, making it difficult for employees to cheat, dilute, or adulterate the test. This test can also be collected on-site, reducing costs and time.

    The most common is a a urine drug test which looks for any traces of substance abuse. The procedure is quick and painless, as simply requires you to provide your urine as a sample for the test. Using this sample, your urine can be tested for alcohol, cocaine, amphetamines, marijuana, opioids (narcotics), PCP, and benzodiazepines.

    However, it’s not all about that because there are also certain policies which protect the privacy of the tested person. Nevertheless, if you are required to take a drug test by a potential employer or for any other reason, it’s important you know what to expect from the procedure.

    Types Of Urine Drug Tests

    Today, there are two different types of urine drug tests. Immunoassay is the first test type which is a cost-effective drug test yielding quick results. There are, however, drawbacks to using this kind of urine test. The test sometimes gives out a false positive result, wherein the test brings a positive result for drugs even if the person is not taking any drugs. This is due to medicinal residue left in the system that can trigger drug tests in numerous ways. When this happens, you’ll have to retake the test.

    RELATED: CBD Might Not Cause You To Fail a Drug Test, But CBN Might

    If the drug test comes out positive and you deny using any drugs, you’ll be required to take the second urine drug test type known as gas chromatography/mass spectrometry (GC/MS). The second test uses the same urine specimen as the first test. These tests are usually more expensive and could take longer to produce test results. On the plus side they rarely give out any false positives.

    Taking The Urine Test

    No matter what drug you’re testing for, the process in urine test is as the same as taking it through drug testing kits. Since these test kits may be used at home, you can take the test anywhere you’re comfortable or most convenient in, such as a doctor’s clinic, hospital, workplace, or even your own home.

    RELATED: The Crazy Crap People Do To Pass A Drug Test

    Photo by 400tmax/Getty Images

    The following tests are to be followed:

    • You will receive a specimen cup from the person administering the test
    • You will have to leave behind your belongings in another room as you take the test. There are some instances wherein you may be required to change into a hospital gown so you can easily take the test.
    • To make sure that you don’t try to skew the test results, a nurse or a technician may accompany you into the bathroom.
    • Before starting, make sure to clean your genital area with the provided moist cloth.
    • Start urinating into the toilet, as you would normally do.
    • While you are urinating, make sure to catch sample into the cup midstream. Don’t let the cup touch your genital area.
    • When done, put a lid on the cup. Bring it to the technician so it can be processed.

    Test Results

    Once you have supplied your specimen sample, the technician or nurse will inform you of when your test results will be available. With the use of an Immunoassay test, you should be able to get your results right away. In the event that your test results to positive for illegal drugs you haven’t taken make sure you request for a GC/MS test right away.

    Anthony Washington

    Source link

  • Michigan Government Jobs No Longer Requires Pre-Employment Marijuana Testing – Cannabis Business Executive – Cannabis and Marijuana industry news

    Michigan Government Jobs No Longer Requires Pre-Employment Marijuana Testing – Cannabis Business Executive – Cannabis and Marijuana industry news





    Michigan Government Jobs No Longer Requires Pre-Employment Marijuana Testing – Cannabis Business Executive – Cannabis and Marijuana industry news





























    skip to Main Content

    AggregatedNews

    Source link

  • As horse racing’s best trainers rake in millions, records show they’ve violated rules aimed at keeping the animals safe | CNN

    As horse racing’s best trainers rake in millions, records show they’ve violated rules aimed at keeping the animals safe | CNN



    CNN
     — 

    As horse racing’s elite saddle up for the final race of the coveted Triple Crown at New York’s Belmont Stakes, the sport’s top trainers will face off for their share of the $1.5 million purse at the lavish, star-studded event – amid growing scrutiny after a recent spate of horse deaths.

    A CNN analysis of disciplinary records found that the top earning trainers in the sport – whose thoroughbreds win them millions of dollars – have all broken rules meant to keep their horses safe. Trainers slapped with violations have continued racing, pocketing winnings while paying minimal fines.

    Records show that horse racing’s most successful trainers have violated the sport’s rules multiple times over the course of thousands of races across decades-long careers. The violations range from failed drug tests on race day to falsifying a trainer license. At least three of the trainers have horses competing at the Belmont Stakes this weekend.

    Many of the violations center on the use of drugs that could mask pain prior to a race, potentially leading racehorses – bred for speed with spindly legs – to run on preexisting injuries that increase the risk of fatal breakdowns on the tracks. Researchers have found that about 90% of fatal horse injuries involve preexisting issues, such as small fractures that weaken horses’ bones.

    While therapeutic medications are often legal for treating horses, several are banned on race day.

    “If a horse has an anti-inflammatory, it could compromise an inspection,” said Dr. Jennifer Durenberger, a veterinarian with the Horseracing Integrity and Safety Authority, the national regulatory body established in 2020. “It’s one of the reasons we do restrict medications in the pre-race period.”

    In many ways, the violations say more about the sport than the trainers themselves. Historically, drug limits and rules have varied from state to state, and punishments, which typically led to fines of a few hundred dollars, seemed more like slaps on the wrists than true deterrents. Trainers suspended from one racetrack were still able to compete on others.

    Horse racing reform advocates, and even some trainers, say that national standards for drug violations will help with compliance and improve horse safety.

    Trainers and their representatives interviewed by CNN, however, largely dismissed their disciplinary records, citing unaccredited testing labs, sensitive testing which picks up on minute traces of medication and inconsistent rules among tracks that led to mistakes often beyond their control. They also say the violations must be placed in the context of the thousands of races their horses have started.

    It was supposed to be a triumphant comeback for legendary horse trainer Bob Baffert, but his Preakness Stakes win was underscored by tragedy.

    Just hours before a horse he trained, National Treasure, won the second-leg of the Triple Crown last month, Baffert’s powerful bay-colored colt, Havnameltdown, suffered an injury to its fore fetlock, the equivalent of an ankle, during an earlier race that day. A veterinarian deemed the injury “non-operable,” leaving the three-year-old horse to be euthanized on the track. The Maryland Racing Commission is investigating the death.

    During his short life, Havnameltdown earned $708,000 in prize money for his handlers, including Baffert, who has said the horse got “hit pretty hard” by another horse coming out of the starting gate.

    The Maryland race marked Baffert’s anticipated return to a Triple Crown race – the first since his 2021 Kentucky Derby win was disqualified after his horse, Medina Spirit, failed a post-race drug test. Baffert was cited by the state horse racing commission and Churchill Downs handed him a suspension that banned him from the next two Derby races.

    The drug test revealed that Medina Spirit had betamethasone in his system. The drug is legal for horses in Kentucky, but state rules don’t allow any detectable levels on race day. Baffert disputed the test result and appealed the commission’s citation.

    During his suspension, Baffert continued to race at other tracks and claimed his cut of millions in prize money. Months after the Derby, Medina Spirit died while training at California’s Santa Anita Park; the necropsy report was inconclusive.

    Equine deaths are quite common – hundreds die on and off the track annually. The root cause of what can bring down a massive, muscular horse can range from the natural to the exploitive, including being overworked and overdrugged in the quest for winnings.

    But while some deaths are difficult to prevent, the recent spate of tragedies, especially ones like the public euthanasia of Havnameltdown, have cast a dark shadow over the multi-billion-dollar industry.

    In the span of a month, 12 horses died at Churchill Downs, Kentucky’s most prominent track, since the stable opened this season. The track has suspended racing there while the fatalities are investigated.

    Bob Baffert-trained horse Havnameltdown, behind the curtain, had to be euthanized on May 20, 2023, during the sixth race of Preakness Day in Baltimore.

    The deaths sparked public outrage and thrust the industry back into the national spotlight just a week after HISA rolled out regulations that include medication control.

    But that’s done little to assuage critics’ concerns over the treatment of horses in what was once called the sport of kings.

    “All of it sounds really impressive and it’s quite a show, but that’s all it is: A show. Meanwhile, the horses continue to die,” said Patrick Battuello, an advocate who has tracked horse deaths for the last decade. “The killing is built into the system. … In what other sport are the athletes drugged and doped without their consent?”

    Defenders of the sport argue that the number of horse racing deaths have declined in recent years, and that the industry is safer than it ever was. They point to falling annual death counts collected by The Jockey Club, an influential industry organization, which reports the number of horses who die or are euthanized after racing injuries. The group has tallied several hundred racing deaths each year, with 328 in 2022, down from 709 a decade earlier.

    But those numbers don’t include horses who die during training or between races, which critics argue leads to a severe undercounting of deaths in the sport. They also only include thoroughbred horses, not quarter horses and standardbred horses. Battuello has tallied more than 9,500 racehorses that died since 2014, largely based on death records he’s collected from state horse racing commissions – roughly 1,000 a year.

    While the exact rules vary from state to state, trainers are generally required to report horse deaths that occur at racetracks or as a result of injuries sustained during races. Most deaths are categorized as racing-related or training-related.

    In a statement, The Jockey Club argued that its numbers were “the most accurate data possible” and noted that it had different criteria for including racing-related deaths than Battuello.

    The sport’s highest-earning trainers were among those who had the most horses die at racetracks or due to racing injuries, according to a CNN analysis of state records collected by Battuello over the last decade, as well as data from the horse racing website Equibase.

    Some prominent trainers saw far more of their horses die during training than in actual races. CNN’s review found that Todd Pletcher, who’s earned more than any horse trainer in the industry over the course of his career, has trained at least 38 horses whose deaths were reported to state racing commissions since 2014.

    Trainer Todd Pletcher watches a workout at Churchill Downs Tuesday, May 2, 2023, in Louisville, Kentucky.

    More than three-fourths of those deaths were related to training, not racing, according to Battuello’s count – meaning that Pletcher largely avoided the national spotlight shone on deaths that took place during prominent races like the Preakness or Belmont.

    Similarly, four of the seven deceased horses trained by Baffert that CNN documented did not die as a direct result of injuries sustained during races, and thus likely wouldn’t be included in the official tally of deaths counted by The Jockey Club.

    CNN’s review is an undercount of deaths because it only counted deaths reportable to state commissions. The review connected horses to their most recent trainer of record as of their last race – so it’s possible that some of the horses could have moved to a different trainer before their deaths.

    Horse trainers bear the ultimate responsibility for the wellbeing of the horse and adherence to the rules on the track, an industry standard known as the “absolute insurer rule.”

    “We are completely responsible for the horses. When they arrive on the racetrack that day, we’re responsible for what’s going into that horse, whether it’s medication or feed,” said Graham Motion, a 30-year horse trainer in Maryland. “That has to be our responsibility. There’s no other way really to make it work.”

    The most successful trainers in the sport have all been cited for medical or drug violations.

    Pletcher has racked up nine drug-related violations throughout his career. On one occasion, regulators found he broke rules regarding Lasix – known as the “water drug” – which makes a horse urinate and potentially run faster. New regulations have banned the drug – though state commissions can apply for three-year exemptions – while the effect on horse safety is studied, according to HISA.

    Pletcher was suspended for 10 days last month, after a delayed drug test showed that his horse, Forte, had elevated levels of a common pain-reliever and anti-inflammatory drug during a race he won in New York back in September.

    Irad Ortiz Jr. rides Forte to victory during the Breeders' Cup Juvenile race at Keenelend Race Course, on Nov. 4, 2022, in Lexington, Kentucky.

    “Forte came into our care on March 25, 2022, and he has never been prescribed or administered meloxicam,” Pletcher, who did not respond to CNN’s multiple requests for comment, told Bloodhorse.com. “We did an internal investigation and could not find an employee who had used the drug.”

    Records show Pletcher plans to appeal the ruling.

    Baffert, too, was suspended after his horse, Medina Spirit – who placed first in a 2021 race at Churchill Downs – tested positive for an anti-inflammatory. The suspension was one of about two dozen drug-related violations during Baffert’s career; the vast majority included anti-inflammatories like betamethasone and phenylbutazone.

    One of the three highest earning trainers, Steve Asmussen, has been cited for violations of medication rules about 40 times, in many instances finding elevated levels of anti-inflammatories or thyroid medication, according to records from the Association of Racing Commissioners International, an umbrella organization of horse racing regulators. Research has shown thyroid medication in horses can cause cardiac arrythmias and new regulations ban its use in thoroughbreds, including on race day.

    Clark Brewster, an attorney for both Baffert and Asmussen, said the tally of violations from ARCI data paints an unfair picture of his clients because many of those citations involved therapeutic medications that only slightly exceeded allowable limits in the rules, which he said have repeatedly shifted. “These guys are painstakingly trying to get it right.”

    Motion, the veteran Maryland trainer, himself has been cited at least twice in his career for medication violations, once after one of his horses tested positive for methocarbamol – a muscle relaxer that is permissible to treat horses, but not allowed on race day.

    “It was a very difficult time for me. And I fought it. And I almost regret fighting it now,” said Motion, adding that he felt his team “handled the medication the proper way.”

    He said the new rules around when horses need to withdraw from such medication ahead of race day could have prevented this type of incident.

    Trainer Steve Asmussen before the 149th running of the Kentucky Oaks on May 5, 2023, at Churchill Downs in Louisville, Kentucky.

    Some therapeutic drugs, including anti-inflammatories, are a big concern for the industry on race day. Before each race, horses are examined by veterinarians to determine their fitness and identify potential ailments. But medication in the horse’s system, like anti-inflammatories, can mask some of those preexisting injuries.

    “The extent [of the preexisting injury] can change dramatically and it can go from something minor to something that is potentially serious, if not life threatening” when a horse bursts onto the track from the starting stall, said Dr. Mary Scollay, chief of science at the Horseracing Integrity and Welfare Unit which oversees the new medication control regulations under HISA.

    New HISA regulations, implemented last month, include strict rules about withdrawal times and allowable medication levels on race day.

    “We want to make sure that there is no lingering effects from that medication that could mask a potential injury that would put that horse at risk to the horse, the rider, the others that are in that race,” said Dr. Will Farmer, equine medical director at Churchill Downs Incorporated. “That’s why we have very strict regulation around use of therapeutics in regards to a race specifically.”

    For decades, a patchwork of local and state rules governed the racetracks in the United States, and trainers found in violation of the rules meant to keep their horses safe have been met with minimal repercussions.

    Pletcher – whose horses have earned more than $460 million in almost 25,000 races – paid $5,000 in fines for drug-related citations over the course of his 27-year career. Baffert and Asmussen were each fined over $30,000 during their decades-long careers, according to records from the racing commissioners association. Those fines are offset by more than $340 million and $410 million in earnings, respectively, according to Equibase.

    What’s more, suspensions only banned trainers from certain tracks, allowing them to continue racing – and pocketing earnings – in other states.

    Since the 2022 New York race where Pletcher’s horse Forte had a post-race positive drug test, the horse won four more competitions for Pletcher, earning his handlers more than $2 million.

    Forte is set to race this weekend and is one of the favorites to win the Belmont Stakes.

    Baffert, too, was able to continue racing after he was hit with the suspension following Medina Spirit’s positive drug test. During that time, Baffert entered hundreds of races on other tracks, competing for purses totaling nearly $125 million, according to Equibase data. In 2022 alone, Baffert’s horses brought in nearly $10 million in prize money.

    A general view at the start during the 145th running of the Kentucky Derby at Churchill Downs.

    The biggest change in the governance of American horse racing was tucked into a 2020 federal spending bill. That proviso ultimately created the national Horseracing Integrity and Safety Authority, or HISA – a move that, after three previous legislative attempts, found support from federal lawmakers after a particularly deadly season at a California racetrack.

    During the 2018-2019 season, a staggering 56 horses died at one of the most glamorous racetracks in the country, Santa Anita Park, once home to the famous 1940s thoroughbred Seabiscuit.

    The California Horse Racing Board could not determine a common denominator for the fatalities but found that the vast majority of horses that died had preexisting injuries. And, while no illegal substances or procedures were found, many of the horses were on anti-inflammatories and various other medications.

    “Horse racing must develop a culture of safety first,” the California board wrote in its investigative report. “A small number of participants refusing to change will harm the entire industry.”

    Initially a local scandal, the deaths in Santa Anita Park would have national implications. The fatalities led not only to a complete overhaul of racing practices in Santa Anita – improved track maintenance, restrictions on the use of medications, and softer whips on race day – but also to new national rules under the new regulator, HISA.

    As a private entity under the supervision of the Federal Trade Commission, HISA creates uniform regulations and penalties to govern racetracks throughout the country. The latest set of rules, implemented last month, include anti-doping and medication control programs. They also state that any suspension for a rule violation will carry across all tracks under HISA’s jurisdiction.

    HISA CEO Lisa Lazarus said the goal is to ensure that “there is a level playing field, that the horses are treated properly, that there is built-in safety and integrity” in the sport.

    But some pockets of the industry aren’t welcoming the changes – most notably the National Horsemen’s Benevolent and Protective Association, which has questioned the constitutionality of HISA and filed suits arguing regulatory overreach.

    In an annual NHBPA conference held in March, trainers spoke out against HISA citing an increased administrative burden and added costs of higher fees and required veterinary checks.

    “The whole thing is a façade. It’s been all smoke and mirrors,” said Bret Calhoun, a horse trainer and member of the Louisiana HBPA board, according to the Thoroughbred Daily News. “They sold this thing as the safety of the horse. It’s absolutely not about safety of horse. It’s a few people, with self-interest and they have their own personal agenda.”

    There are several lawsuits challenging HISA’s legitimacy and authority in the sport, some backed by the NHBPA, making their way through courts across the country. But while legal battles are fought in the courts, horses keep dying on the tracks.

    Last week, a horse death at Belmont Park meant that there have been fatalities around all three racetracks in the Triple Crown this season.

    “There is risk in any sport. We cannot eliminate risk. We can continue to diminish risk as best we can. We are never going to eliminate a horse getting injured,” said Motion, adding “the most important thing is the welfare of the horse. It’s not winning at all costs. It’s winning with a healthy animal.”

    To identify racehorses who died while being trained by the industry’s highest-earning trainers, CNN combined a list of dead horses compiled by activist Patrick Battuello with data from the horse racing website Equibase.

    Since 2014, Battuello has collected state horse racing commission reports on horse deaths through public records requests and published a list of racehorses who died each year on his website. Most of the horse deaths Battuello has identified are based on state records, although a handful are based on news reports or verbal confirmation he received from racetrack officials.

    CNN matched Battuello’s list of deceased horses with data downloaded from Equibase that listed each horse’s trainer as of its most recent race. For the top three trainers with the highest earnings, Pletcher, Asmussen and Baffert, CNN reviewed the original documents Battuello collected from the commissions, which he provided to reporters.

    Because the Equibase data on trainers is based on each horse’s most recent race, some horses may have moved to other trainers before they died. In a handful of cases, when state death records listed a different trainer for a horse than Equibase does, CNN used the trainer listed in the records.

    CNN’s review only included horse deaths that were required to be reported to state commissions, so it undercounts the total deaths associated with individual trainers. In addition, not all of the dead horses Battuello has documented were able to be reliably matched with Equibase’s data, so additional deaths may also be missing from the review.

    Source link

  • More workers testing positive for marijuana, annual index shows – Medical Marijuana Program Connection

    More workers testing positive for marijuana, annual index shows – Medical Marijuana Program Connection

    Secaucus, NJ — The percentage of workers testing positive for marijuana after an on-the-job incident or injury hit a 25-year high in 2022, according to an analysis conducted by Quest Diagnostics.

    Researchers from the lab services provider examined the results of more than 10.6 million samples taken last year from the combined U.S. workforce – both the general workforce and employees in safety-sensitive jobs who undergo federally mandated drug testing (including pilots, truck drivers and train conductors) – for the annual Quest Diagnotics’ Drug Testing Index. Overall, 7.3% of the samples tested positive – up from 6.7% in 2021, for a 9% increase.

    Over the past decade, post-incident marijuana positivity has soared by 204.2%. Although marijuana use remains illegal under federal law, its medical use has been legalized in 38 states and the District of Columbia, and 21 states and the District of Columbia allow recreational use. 

    Marijuana positivity was highest in accommodation and food services (7%) and retail trade (7.7%) – rising 42.9% and 42.6%, respectively, from 2018.

    Among the federally mandated, safety-sensitive workforce, marijuana positivity jumped 14%.

    Katie Mueller, a National Safety Council senior program manager focused on cannabis safety, suggests that employers create and maintain a cannabis-use policy, build a safety-focused workplace culture, and educate workers to keep everyone safe on the job.

    “Intoxicating cannabis products,…

    Original Author Link click here to read complete story..

    MMP News Author

    Source link

  • The Bluegrass State Has Gone Green – Medical Marijuana Program Connection

    The Bluegrass State Has Gone Green – Medical Marijuana Program Connection

    Kentucky has become the 38th state in the U.S. to legalize cannabis for medical use. While the new law legitimizes the use of marijuana for medical purposes, it fails to afford lawful users employment protections, permitting employers to enforce “zero-tolerance” workplace policies. Further, it places specific obligations on workers who use medical cannabis to prove their innocence regarding impairment.

    The law comes after an executive order issued by Kentucky Governor Andy Beshear in 2022 that allowed Kentucky residents with qualifying medical conditions to possess and use small amounts of legally purchased medical marijuana. Legalization has been an important issue for Beshear, a Democrat, who governs a state with a Republican legislature.

    Under the new law, individuals eligible for treatment of “qualifying medical conditions” may possess a 30-day supply of cannabis at their residence and a 10-day supply on their person. While individuals may not smoke marijuana, vaping is permitted. Qualifying medical conditions include cancer, chronic, severe, intractable, or debilitating pain, epilepsy or other seizure disorders, multiple sclerosis, muscle spasms or spasticity, chronic nausea, post-traumatic stress disorder, or any other condition identified by the state’s regulator. Individuals under the age of 18 are eligible for treatment…

    Original Author Link click here to read complete story..

    MMP News Author

    Source link

  • Cordant Awarded SAMHSA Certification for Ninth Continuous Year: Company Doubles Down on Quality Control in Support of Patient Care

    Cordant Awarded SAMHSA Certification for Ninth Continuous Year: Company Doubles Down on Quality Control in Support of Patient Care

    Press Release



    updated: Aug 9, 2018

    Cordant Health Solutions™, which provides innovative tools for monitoring behavioral health and chronic pain through its unique pharmacy and drug testing programs, is pleased to announce the renewal of its Substance Abuse and Mental Health Services Administration (SAMHSA) certification for its forensic drug testing program that enables Cordant to test specimens for federal agencies.

    Cordant has successfully met the strict standards for SAMHSA certification continuously since April 2009 and is currently one of only 27 toxicology companies to hold this certification, one of the most rigorous quality control certification programs in forensic testing.

    Quality control programs like SAMHSA and CAP FDT, CAP and CLIA challenge us to maintain the highest level of analytical precision and accuracy and ensure that test results are both accurate and reliable. Our emphasis is always on continuous quality improvement.

    Richard Stripp, Ph.D., chief scientific and technical officer

    As evidence of the company’s dedication to operational excellence, Cordant is also accredited by the College of American Pathologists for forensic drug testing (CAP FDT), which has stringent requirements for screening and confirmation testing, quality control, and external and internal chain-of-custody procedures which focuses on law enforcement testing.

    Cordant is also one of only two toxicology companies outside of California to attain a California license for methadone testing, a medication used in the treatment of opioid use disorder. In addition, Cordant is CAP-accredited and CLIA-certified and is licensed for clinical testing in many states, including New York.

    “Quality control programs like SAMHSA and CAP FDT, CAP and CLIA challenge us to maintain the highest level of analytical precision and accuracy and ensure that test results are both accurate and reliable. Our emphasis is always on continuous quality improvement,” said Richard Stripp, Ph.D., chief scientific and technical officer at Cordant. “We view strict internal acceptance criteria as table stakes when it comes to patient results. Test results are not just numbers in a file — they affect lives. We take that responsibility very seriously.”

    About Cordant

    Based in Denver, Cordant Health Solutions™ (www.cordantsolutions.com) provides innovative tools for monitoring behavioral health, chronic pain and criminal justice cases. Our unique pharmacy and drug testing programs provide accurate, actionable results to protect prescribers, hold patients accountable and optimize quality of life.

    As a leader in rigorous quality standards, Cordant is committed to developing groundbreaking solutions for payers, clinicians and organizations involved with substance use disorder, criminal justice and pain management. Cordant is one of the only healthcare companies that offers monitoring and risk assessment tools through its innovative drug testing options and full-service, high-touch pharmacies, which specialize in the complex management and dispensing of controlled substances. Cordant’s testing protocols and digital case-management tools help clients become more efficient and effective in using drug testing programs to monitor patient adherence, reduce risk and improve patient outcomes.

    Media Contact:
    Tiffany Tuetken
    303-570-4585
    ttuetken@cordanths.com
    cordantsolutions.com

    Source: Cordant Health Solutions

    Source link